Drawing for CARSGEN

USPTO serial 79268545

CARSGEN

Reviewed by CopyMark Law Group

Reg. 6093160Status 700Renewal
Filing date
Status date
Registration date
Jul 7, 2020
Examiner
SALES, HEATHER ALISON
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CARSGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adam Bell

Adam Bell Bell IP Law58 West Portal Avenue #121San Francisco, CA 94127United States

Goods and services

ClassDescriptionStatusFirst use
005Injectable pharmaceuticals for treatment of cancer and autoimmune diseases and disorders; liquid medicine for treatment of cancer and autoimmune diseases and disorders; biological preparations for the treatment of cancer and autoimmune diseases and disorders; drug delivery agents in the form of injections for medical purposes for the treatment of cancer and autoimmune diseases and disorders; vaccine preparations; pharmaceutical preparations for cancer and immunotherapy; blood for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic preparations for medical purposesACTIVE—
010Medical apparatus and instruments, namely, sample preparation devices for medical diagnostic use and for the treatment of cancer and autoimmune diseases and disorders and apparatus for the regeneration of stem cells for medical purposes; diagnostic apparatus for medical purposes for detecting cancer and autoimmune diseases and disorders; apparatus for use in medical analysis in the fields of cancer and immunology ; testing apparatus for medical purposes for DNA; surgical apparatus and instruments; medical apparatus and instruments for use in otolaryngology; dental apparatus and instruments, namely, intra-oral light systems; uterine syringes; medical apparatus used in physiotherapy; electrodes for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Aug 24, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 22, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
May 8, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 8, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 7, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 21, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 2, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 2, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 7, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 7, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 27, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 27, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 27, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 22, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 2, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 2, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 16, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 15, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 10, 2019DOCKASSIGNED TO EXAMINER—
Oct 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 3, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance